Episode

How Wearables Are Transforming Oncology Care

Podcast
AI and Healthcare
Published
Dec 5, 2025
Duration seconds
3538
Processing state
not_requested
Canonical source
https://mtrudnak.podbean.com/e/how-wearables-are-transforming-oncology-care/
Audio
https://mcdn.podbean.com/mf/web/qbqfcexx5rw45n7f/Episode_104_Audio68iou.mp3
JSON
/v1/public/podcasts/ai-and-healthcare-5049686/episodes/how-wearables-are-transforming-oncology-care
Markdown
/podcast/ai-and-healthcare-5049686/how-wearables-are-transforming-oncology-care.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/ai-and-healthcare-5049686/episodes/how-wearables-are-transforming-oncology-care/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/ai-and-healthcare-5049686/how-wearables-are-transforming-oncology-care.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Continuous monitoring is reshaping oncology. CEO of AION Biosystems, Sam Barend, joins Dr. Sanjay Juneja, Dr. Douglas Flora, and Dr. David Penberthy to explore how long‑term physiologic tracking, AI‑driven insights, and clinically validated wearables are improving outcomes for patients at high risk of complications. The conversation highlights FDA pathways, reimbursement realities, and the promise of simpler, signal‑focused monitoring that detects patterns earlier and supports safer treatment continuity.